TriaGen Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,186
Closed -$2.42M 190
2025
Q4
$2.42M Buy
+25,186
New +$2.45M 0.63% 35
2021
Q4
Sell
-5,690
Closed -$713K 193
2021
Q3
$713K Hold
5,690
0.39% 83
2021
Q2
$747K Hold
5,690
0.38% 82
2021
Q1
$672K Sell
5,690
-72
-1% -$8.44K 0.39% 81
2020
Q4
$675K Buy
+5,762
New +$634K 0.4% 82

Other funds holding MDT

TriaGen Wealth Management's MDT Position: Q1 2026 in Review

TriaGen Wealth Management sold out of Medtronic (MDT) in Q1 2026, closing a stake of 25,186 shares — an estimated $2.42M sold.

TriaGen Wealth Management first reported a position in MDT in Q4 2020 and held it in 5 quarters. The position peaked at $2.42M in Q4 2025. 2,248 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • TriaGen Wealth Management reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • TriaGen Wealth Management sold 25,186 Medtronic shares in Q1 2026, an estimated $2.42M.
  • TriaGen Wealth Management first reported a position in Medtronic in Q4 2020 and held it in 5 quarters.
  • TriaGen Wealth Management's Medtronic position peaked at $2.42M in Q4 2025.
  • 2,248 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on TriaGen Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.